NCT05758571View on ClinicalTrials.gov

Oxygen Atomizing Inhalation of EGCG in the Treatment Interstitial Pneumonia in Cancer Patients

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

January 5, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2025

Conditions
Interstitial PneumoniaNeoplasms Malignant
Interventions
DRUG

EGCG

EGCG (high pressure liquid chromatographic purity ≥ 95%; from Ningbo Hepu Biotechnology Co., Ltd.) is dissolved in 0.9% normal saline; 10ml is inhaled by atomization three times a day.

Trial Locations (1)

250117

RECRUITING

Shandong Cancer Hospital, Jinan

All Listed Sponsors
lead

Shandong Cancer Hospital and Institute

OTHER